US Stock MarketDetailed Quotes

BRTX Biorestorative Therapies

Watchlist
  • 1.690
  • +0.040+2.42%
Trading Jul 22 14:48 ET
11.44MMarket Cap-1942P/E (TTM)

Biorestorative Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
11.82%35K
21.70%145.8K
421.62%19.3K
5.86%30.7K
-9.28%64.5K
95.63%31.3K
160.43%119.8K
-26.00%3.7K
262.50%29K
374.00%71.1K
Operating revenue
11.82%35K
21.70%145.8K
421.62%19.3K
5.86%30.7K
-9.28%64.5K
95.63%31.3K
160.43%119.8K
-26.00%3.7K
262.50%29K
374.00%71.1K
Cost of revenue
Gross profit
Operating expense
-28.68%4.14M
-19.49%15.28M
-29.44%3.24M
-34.21%3.05M
-32.31%3.18M
14.99%5.81M
-27.97%18.98M
14.39%4.59M
25.48%4.64M
31.64%4.7M
Selling and administrative expenses
-32.60%3.09M
-27.27%11.33M
-36.21%2.56M
-38.07%2.26M
-38.94%2.21M
6.62%4.58M
-39.20%15.58M
4.24%4.01M
5.50%3.65M
6.31%3.62M
-General and administrative expense
-32.60%3.09M
-27.27%11.33M
-36.21%2.56M
-38.07%2.26M
-38.94%2.21M
6.62%4.58M
-39.20%15.58M
4.24%4.01M
5.50%3.65M
6.50%3.62M
Research and development costs
-14.09%1.06M
14.84%4.03M
1.04%680.63K
-11.56%874.82K
-9.98%967.89K
58.87%1.23M
381.90%3.51M
307.03%673.62K
316.65%989.17K
568.26%1.08M
Other operating expenses
----
24.60%-83.33K
--0
---83.33K
----
----
---110.52K
---93.86K
----
----
Operating profit
28.89%-4.11M
19.75%-15.14M
29.80%-3.22M
34.46%-3.02M
32.67%-3.12M
-14.73%-5.78M
28.30%-18.86M
-14.44%-4.59M
-24.97%-4.61M
-30.19%-4.63M
Net non-operating interest income expense
792.61%162.6K
4,640.71%552.29K
224.01%376.22K
313.82%61.67K
306.35%96.19K
162.79%18.22K
100.64%11.65K
154.31%116.12K
94.18%-28.84K
90.81%-46.61K
Non-operating interest income
792.61%162.6K
4,640.71%552.29K
----
----
----
--18.22K
--11.65K
----
----
----
Total other finance cost
----
----
----
-313.82%-61.67K
-306.35%-96.19K
----
----
----
--28.84K
--46.61K
Other net income (expense)
222.08%1.72M
-25.97%4.17M
-25.57%4.02M
296.43%33.95K
39.81K
-664.68%-1.41M
134.79%5.63M
5.4M
-17.28K
Gain on sale of security
205.78%1.57M
-24.18%4M
----
----
----
---1.49M
--5.27M
----
----
----
Special income (charges)
----
--0
--0
--0
--0
----
--250K
--0
--0
--0
-Less:Other special charges
----
----
----
----
----
----
---250K
--0
----
----
Other non- operating income (expenses)
94.39%149.02K
58.43%169.66K
-84.53%19.24K
296.43%33.95K
--39.81K
--76.66K
100.66%107.09K
--124.37K
---17.28K
----
Income before tax
69.00%-2.22M
21.21%-10.42M
26.77%1.17M
37.16%-2.93M
36.25%-2.98M
-48.93%-7.17M
70.16%-13.22M
104.53%924.92K
-11.27%-4.66M
-15.08%-4.68M
Income tax
Net income
69.00%-2.22M
21.21%-10.42M
26.77%1.17M
37.16%-2.93M
36.25%-2.98M
-48.93%-7.17M
70.16%-13.22M
104.53%924.92K
-11.27%-4.66M
-15.08%-4.68M
Net income continuous Operations
69.00%-2.22M
21.21%-10.42M
26.77%1.17M
37.16%-2.93M
36.25%-2.98M
-48.93%-7.17M
70.16%-13.22M
104.53%924.92K
-11.27%-4.66M
-15.08%-4.68M
Minority interest income
Net income attributable to the parent company
69.00%-2.22M
21.21%-10.42M
26.77%1.17M
37.16%-2.93M
36.25%-2.98M
-48.93%-7.17M
70.16%-13.22M
104.53%924.92K
-11.27%-4.66M
-15.08%-4.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
69.00%-2.22M
21.21%-10.42M
26.77%1.17M
37.16%-2.93M
36.25%-2.98M
-48.93%-7.17M
70.16%-13.22M
104.53%924.92K
-11.27%-4.66M
-15.08%-4.68M
Basic earnings per share
82.90%-0.33
32.33%-2.47
35.71%0.38
50.00%-0.64
39.84%-0.77
-40.88%-1.93
90.21%-3.65
104.83%0.28
74.37%-1.28
73.63%-1.28
Diluted earnings per share
82.90%-0.33
32.33%-2.47
35.71%0.38
50.00%-0.64
39.84%-0.77
-40.88%-1.93
90.21%-3.65
104.83%0.28
74.37%-1.28
73.63%-1.28
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 11.82%35K21.70%145.8K421.62%19.3K5.86%30.7K-9.28%64.5K95.63%31.3K160.43%119.8K-26.00%3.7K262.50%29K374.00%71.1K
Operating revenue 11.82%35K21.70%145.8K421.62%19.3K5.86%30.7K-9.28%64.5K95.63%31.3K160.43%119.8K-26.00%3.7K262.50%29K374.00%71.1K
Cost of revenue
Gross profit
Operating expense -28.68%4.14M-19.49%15.28M-29.44%3.24M-34.21%3.05M-32.31%3.18M14.99%5.81M-27.97%18.98M14.39%4.59M25.48%4.64M31.64%4.7M
Selling and administrative expenses -32.60%3.09M-27.27%11.33M-36.21%2.56M-38.07%2.26M-38.94%2.21M6.62%4.58M-39.20%15.58M4.24%4.01M5.50%3.65M6.31%3.62M
-General and administrative expense -32.60%3.09M-27.27%11.33M-36.21%2.56M-38.07%2.26M-38.94%2.21M6.62%4.58M-39.20%15.58M4.24%4.01M5.50%3.65M6.50%3.62M
Research and development costs -14.09%1.06M14.84%4.03M1.04%680.63K-11.56%874.82K-9.98%967.89K58.87%1.23M381.90%3.51M307.03%673.62K316.65%989.17K568.26%1.08M
Other operating expenses ----24.60%-83.33K--0---83.33K-----------110.52K---93.86K--------
Operating profit 28.89%-4.11M19.75%-15.14M29.80%-3.22M34.46%-3.02M32.67%-3.12M-14.73%-5.78M28.30%-18.86M-14.44%-4.59M-24.97%-4.61M-30.19%-4.63M
Net non-operating interest income expense 792.61%162.6K4,640.71%552.29K224.01%376.22K313.82%61.67K306.35%96.19K162.79%18.22K100.64%11.65K154.31%116.12K94.18%-28.84K90.81%-46.61K
Non-operating interest income 792.61%162.6K4,640.71%552.29K--------------18.22K--11.65K------------
Total other finance cost -------------313.82%-61.67K-306.35%-96.19K--------------28.84K--46.61K
Other net income (expense) 222.08%1.72M-25.97%4.17M-25.57%4.02M296.43%33.95K39.81K-664.68%-1.41M134.79%5.63M5.4M-17.28K
Gain on sale of security 205.78%1.57M-24.18%4M---------------1.49M--5.27M------------
Special income (charges) ------0--0--0--0------250K--0--0--0
-Less:Other special charges ---------------------------250K--0--------
Other non- operating income (expenses) 94.39%149.02K58.43%169.66K-84.53%19.24K296.43%33.95K--39.81K--76.66K100.66%107.09K--124.37K---17.28K----
Income before tax 69.00%-2.22M21.21%-10.42M26.77%1.17M37.16%-2.93M36.25%-2.98M-48.93%-7.17M70.16%-13.22M104.53%924.92K-11.27%-4.66M-15.08%-4.68M
Income tax
Net income 69.00%-2.22M21.21%-10.42M26.77%1.17M37.16%-2.93M36.25%-2.98M-48.93%-7.17M70.16%-13.22M104.53%924.92K-11.27%-4.66M-15.08%-4.68M
Net income continuous Operations 69.00%-2.22M21.21%-10.42M26.77%1.17M37.16%-2.93M36.25%-2.98M-48.93%-7.17M70.16%-13.22M104.53%924.92K-11.27%-4.66M-15.08%-4.68M
Minority interest income
Net income attributable to the parent company 69.00%-2.22M21.21%-10.42M26.77%1.17M37.16%-2.93M36.25%-2.98M-48.93%-7.17M70.16%-13.22M104.53%924.92K-11.27%-4.66M-15.08%-4.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 69.00%-2.22M21.21%-10.42M26.77%1.17M37.16%-2.93M36.25%-2.98M-48.93%-7.17M70.16%-13.22M104.53%924.92K-11.27%-4.66M-15.08%-4.68M
Basic earnings per share 82.90%-0.3332.33%-2.4735.71%0.3850.00%-0.6439.84%-0.77-40.88%-1.9390.21%-3.65104.83%0.2874.37%-1.2873.63%-1.28
Diluted earnings per share 82.90%-0.3332.33%-2.4735.71%0.3850.00%-0.6439.84%-0.77-40.88%-1.9390.21%-3.65104.83%0.2874.37%-1.2873.63%-1.28
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg